FDA to decide on TG Therapeutics’ lymphoma drug early next year

FDA to decide on TG Therapeutics’ lymphoma drug early next year

Submitted by admin on August 13, 2020 - 11:53pm
Source: 
Pharmaforum
News Tags: 
TG Therapeutics
FDA
lymphoma
umbralisib
Bristol-Myers Squibb
Roche
Headline: 
FDA to decide on TG Therapeutics’ lymphoma drug early next year
snippet: 

The FDA has accepted TG Therapeutics’ filing for its lymphoma drug umbralisib, which if approved could compete against a combination therapy from Bristol-Myers Squibb and Roche.

Do Not Allow Advertisers to Use My Personal information